These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1105320)

  • 1. Mechanisms of tissue injury in systemic lupus erythematosus.
    Koffler D
    Pathobiol Annu; 1975; 5():221-47. PubMed ID: 1105320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central nervous system manifestations in patients with systemic lupus erythematosus. Review of pathogenetic aspects].
    Wollina U
    Psychiatr Neurol Med Psychol (Leipz); 1984 May; 36(5):303-6. PubMed ID: 6484056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3 cases of anti-Scl-70 (topoisomerase I) antibody associated with central nervous system lupus without renal disorder.
    Mukai M; Sagawa A; Atsumi T; Jodo S; Amasaki Y; Nakabayashi T; Watanabe I; Fujisaku A; Nakagawa S
    J Rheumatol; 1993 Sep; 20(9):1594-7. PubMed ID: 8164223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
    Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
    J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus of the central nervous system: 2. Molecular theories and models for mental disease.
    Moskowitz N
    Mt Sinai J Med; 1989 Jan; 56(1):23-9. PubMed ID: 2784179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus.
    Boyer RS; Sun NC; Verity A; Nies KM; Louie JS
    J Rheumatol; 1980; 7(5):645-50. PubMed ID: 7003142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative characteristic of circulating immune complexes in patients with lupus erythematosus and central nervous system disorders].
    Ivanova MM; Sykulev IuK; Blizniuk OI; Tumanova IA
    Klin Med (Mosk); 1991 Mar; 69(3):58-60. PubMed ID: 2067339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic kidney diseases].
    Tallgren LG; Skrifvars B
    Duodecim; 1973; 89(2):135-51. PubMed ID: 4685131
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical manifestations of systemic lupus erythematosus, measures of disease activity, and long-term complications.
    Ginzler EM; Antoniadis I
    Curr Opin Rheumatol; 1992 Oct; 4(5):672-80. PubMed ID: 1419501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinico-immunological characteristics of central nervous system involvement in systemic lupus erythematosus: the relationship with antibodies to cardiolipin].
    Travkina IV; Ivanova MM; Nasonov EL; Shmidt TE; Kovalev VIu
    Ter Arkh; 1992; 64(5):10-4. PubMed ID: 1455360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement.
    Teplizki H; Buskila D; Argov S; Isenberg D; Coates AR; Sukenik S; Horowitz J; Shoenfeld Y
    J Rheumatol; 1987 Jun; 14(3):507-11. PubMed ID: 3114486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating immune complexes and clinico-immunologic subtypes of systemic lupus erythematosus. II].
    Nasonov EL; Solov'ev SK; Poverennyĭ AM; Ivanova MM; Tachmuradova MD
    Ter Arkh; 1989; 61(5):38-43. PubMed ID: 2781488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatology Rounds at the Hospital for Special Surgery. Aspects of systemic lupus erythematosus: consideration of viral and genetic factors, and remarks on therapy.
    Christian CL; Mellors RC; Lightfoot RW; Block SR
    Am J Med Sci; 1975; 270(3):515-22. PubMed ID: 174427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the treatment of dermatoses in autoimmunization].
    Miedziński F
    Pol Tyg Lek; 1971 Sep; 26(39):1489-91. PubMed ID: 4940117
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientific overview of systemic lupus erythematosus (SLE).
    Jasin HE
    Prog Clin Biol Res; 1982; 106():65-80. PubMed ID: 6757954
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetic role of anti-vascular endothelial cell antibodies in systemic lupus erythematosus.
    Zhou SF; Wang XM; Zhong HP; Li A; Wang MX; Wang SL; Zhang L; Du XH
    Chin Med J (Engl); 1989 Jul; 102(7):505-9. PubMed ID: 2517066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetic studies on systemic lupus erythematosus.
    Sebastiani GD; Galeazzi M
    Lupus; 2009 Sep; 18(10):878-83. PubMed ID: 19671786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells in the pathogenesis of systemic lupus erythematosus.
    Hoffman RW
    Clin Immunol; 2004 Oct; 113(1):4-13. PubMed ID: 15380523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.